A Randomized Phase 3 Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk Retroperitoneal Sarcoma
Age: 18+
Phase: 3
Locations:
- Birmingham – University Hospitals Birmingham – Queen Elizabeth Medical Centre
- Leeds – Leeds Teaching Hospitals NHS Trust – St James’s University Hospital
- London – The Royal Marsden Hospital
- Nottingham – Nottingham University Hospitals NHS Trust – City Hospital
- Wirral – Clatterbridge Cancer Centre
This study will assess the potential benefits of chemotherapy before surgery to improve disease control and survival in patients with high-risk retroperitoneal sarcoma.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
